10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,627,601 | -19.6% | 39,457 | +8.8% | 0.08% | -25.5% |
| Q2 2023 | $2,024,256 | -19.0% | 36,251 | -19.1% | 0.10% | -14.3% |
| Q1 2023 | $2,498,499 | +111.9% | 44,784 | +38.4% | 0.12% | +70.0% |
| Q4 2022 | $1,179,126 | +27.9% | 32,358 | 0.0% | 0.07% | +12.9% |
| Q3 2022 | $922,000 | -37.0% | 32,358 | 0.0% | 0.06% | -30.3% |
| Q2 2022 | $1,464,000 | -33.5% | 32,358 | +11.9% | 0.09% | -18.3% |
| Q1 2022 | $2,200,000 | -42.4% | 28,923 | +12.9% | 0.11% | -23.8% |
| Q4 2021 | $3,818,000 | +11.9% | 25,629 | +9.4% | 0.14% | -5.9% |
| Q3 2021 | $3,411,000 | -25.7% | 23,433 | 0.0% | 0.15% | -33.6% |
| Q2 2021 | $4,589,000 | +21.4% | 23,433 | +12.2% | 0.23% | +31.6% |
| Q1 2021 | $3,781,000 | +91.6% | 20,889 | +49.9% | 0.17% | +100.0% |
| Q4 2020 | $1,973,000 | +15.2% | 13,933 | +1.5% | 0.09% | -12.1% |
| Q3 2020 | $1,712,000 | +157.4% | 13,733 | +84.5% | 0.10% | +115.2% |
| Q2 2020 | $665,000 | – | 7,444 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |